Peptide TherapeuticsPeer Reviewed

LTr1 alleviates DSS-induced ulcerative colitis by modulating macrophages to inhibit M1 polarization and associated inflammatory responses.

Authors (6)
Wenjing ZhuCollege of Art, Jiangsu Open University, Nanjing, China.
Qian ChengDepartment of Oncology, Nantong University, Nantong, China.
Chang LiuHamilton Institute, Maynooth University, Maynooth, Kildare, Ireland.
Jiacheng QianYancheng Key Laboratory of Molecular Epigenetics, Yancheng Medical Research Center, Nanjing University Medical School, The First People's Hospital of Yancheng, Yancheng, China.
Frontiers in immunology
Unknown
Published
Jan 01, 2025
View Original

Abstract

Abstract not available - data parsing issue resolved

Keywords

LTr1M1 polarizationcolitismacrophagesnetwork pharmacology

Article Metrics

Sourcepubmed

Related Research

Explore more articles in this research category to discover related studies and findings.

View more in Peptide Therapeutics